Victory Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.36M Buy
30,482
+740
+2% +$179K ﹤0.01% 1200
2025
Q1
$7.24M Buy
29,742
+7,525
+34% +$1.83M 0.01% 1166
2024
Q4
$7.3M Buy
22,217
+923
+4% +$303K 0.01% 1168
2024
Q3
$7.12M Buy
21,294
+186
+0.9% +$62.2K 0.01% 1196
2024
Q2
$5.76M Buy
21,108
+3,298
+19% +$901K 0.01% 1225
2024
Q1
$6.16M Buy
17,810
+139
+0.8% +$48.1K 0.01% 1194
2023
Q4
$5.71M Buy
17,671
+5,790
+49% +$1.87M 0.01% 1211
2023
Q3
$4.26M Sell
11,881
-895
-7% -$321K ﹤0.01% 1236
2023
Q2
$4.84M Buy
12,776
+6,273
+96% +$2.38M 0.01% 1211
2023
Q1
$3.12M Sell
6,503
-4,162
-39% -$1.99M ﹤0.01% 1299
2022
Q4
$4.48M Buy
10,665
+2,795
+36% +$1.18M 0.01% 1224
2022
Q3
$3.28M Sell
7,870
-4,438
-36% -$1.85M ﹤0.01% 1342
2022
Q2
$6.09M Sell
12,308
-470
-4% -$233K 0.01% 1204
2022
Q1
$6.56M Sell
12,778
-201
-2% -$103K 0.01% 1242
2021
Q4
$9.81M Buy
12,979
+12
+0.1% +$9.07K 0.01% 1130
2021
Q3
$9.67M Sell
12,967
-591
-4% -$441K 0.01% 1117
2021
Q2
$8.74M Sell
13,558
-4,152
-23% -$2.68M 0.01% 1164
2021
Q1
$10.1M Sell
17,710
-12,558
-41% -$7.17M 0.01% 1139
2020
Q4
$17.6M Sell
30,268
-791
-3% -$461K 0.02% 920
2020
Q3
$16M Buy
31,059
+17,248
+125% +$8.89M 0.02% 894
2020
Q2
$6.24M Sell
13,811
-27,823
-67% -$12.6M 0.01% 1123
2020
Q1
$14.6M Buy
41,634
+23,255
+127% +$8.15M 0.01% 980
2019
Q4
$6.8M Sell
18,379
-1,152
-6% -$426K 0.01% 1115
2019
Q3
$6.5M Buy
19,531
+11,676
+149% +$3.89M 0.01% 1109
2019
Q2
$2.46M Buy
+7,855
New +$2.46M 0.01% 1088
2019
Q1
Sell
-11,385
Closed -$2.64M 1786
2018
Q4
$2.64M Sell
11,385
-53
-0.5% -$12.3K 0.01% 975
2018
Q3
$3.58M Buy
11,438
+3,195
+39% +$1M 0.01% 967
2018
Q2
$2.38M Buy
8,243
+937
+13% +$270K 0.01% 1041
2018
Q1
$1.83M Buy
+7,306
New +$1.83M ﹤0.01% 1091
2017
Q1
Sell
-7,445
Closed -$1.36M 1807
2016
Q4
$1.36M Buy
7,445
+859
+13% +$157K ﹤0.01% 1021
2016
Q3
$1.08M Buy
+6,586
New +$1.08M ﹤0.01% 998